Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GDEN
2001
DELISTED
Golden Entertainment
GDEN
| $1.49M | ﹤0.01% |
37,659
+18,543
| +97% | +$873K |
|
2002
PUT
Sunrun
RUN
$2.49B
| $1.49M | ﹤0.01% |
+63,700
| New | +$1.53M |
|
2003
IPG Photonics
IPGP
$3.7B
| $1.48M | ﹤0.01% |
15,778
-24,189
| -61% | -$2.39M |
|
2004
Acadia Pharmaceuticals
ACAD
$4.39B
| $1.48M | ﹤0.01% |
105,266
+29,280
| +39% | +$546K |
|
|
NETC
2005
DELISTED
Nabors Energy Transition Corp.
NETC
| $1.48M | ﹤0.01% |
147,898
| – | – |
|
|
AHRT
2006
AH Realty Trust
AHRT
$527M
| $1.48M | ﹤0.01% |
115,040
-180,342
| -61% | -$2.45M |
|
|
FLG
2007
Flagstar Bank National Association
FLG
$5.93B
| $1.47M | ﹤0.01% |
53,725
-40,262
| -43% | -$1.16M |
|
2008
SSR Mining
SSRM
$5.6B
| $1.46M | ﹤0.01% |
87,638
-35,437
| -29% | -$732K |
|
2009
Moelis & Co
MC
$5.08B
| $1.46M | ﹤0.01% |
37,153
-5,446
| -13% | -$238K |
|
|
LGAC
2010
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $1.46M | ﹤0.01% |
149,200
| – | – |
|
2011
Southwest Gas
SWX
$6.5B
| $1.46M | ﹤0.01% |
16,772
-226,267
| -93% | -$20M |
|
2012
Alkermes
ALKS
$8.31B
| $1.46M | ﹤0.01% |
48,941
-5,374
| -10% | -$154K |
|
2013
e.l.f. Beauty
ELF
$4.87B
| $1.46M | ﹤0.01% |
47,570
+7,762
| +19% | +$195K |
|
2014
Crane NXT
CXT
$3.09B
| $1.45M | ﹤0.01% |
47,780
+22,750
| +91% | +$757K |
|
2015
Coca-Cola Consolidated
COKE
$12B
| $1.45M | ﹤0.01% |
25,720
-24,810
| -49% | -$1.3M |
|
2016
Globus Medical
GMED
$11.1B
| $1.45M | ﹤0.01% |
25,753
+5,984
| +30% | +$393K |
|
2017
Vanguard Information Technology ETF
VGT
$141B
| $1.44M | ﹤0.01% |
35,328
+13,544
| +62% | +$610K |
|
2018
Dutch Bros
BROS
$8.91B
| $1.44M | ﹤0.01% |
45,503
+23,569
| +107% | +$966K |
|
|
PICC
2019
DELISTED
Pivotal Investment Corporation III
PICC
| $1.44M | ﹤0.01% |
146,794
-50,000
| -25% | -$490K |
|
|
JUN
2020
DELISTED
Juniper II Corp.
JUN
| $1.44M | ﹤0.01% |
144,871
| – | – |
|
2021
ScottsMiracle-Gro
SMG
$3.97B
| $1.44M | ﹤0.01% |
18,209
+17,838
| +4,808% | +$1.76M |
|
|
IRBT
2022
DELISTED
iRobot
IRBT
| $1.44M | ﹤0.01% |
39,037
-14,337
| -27% | -$693K |
|
2023
Hubbell
HUBB
$25.2B
| $1.43M | ﹤0.01% |
8,031
+2,005
| +33% | +$378K |
|
2024
Origin Bancorp
OBK
$1.69B
| $1.43M | ﹤0.01% |
36,913
+4,534
| +14% | +$179K |
|
2025
Supernus Pharmaceuticals
SUPN
$2.67B
| $1.43M | ﹤0.01% |
49,490
-17,556
| -26% | -$503K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.